Sale!

PRX Gene Dejerine-Sottas Disease Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PRX Gene Dejerine-Sottas Disease NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the PRX gene associated with Dejerine-Sottas disease, a severe form of hereditary motor and sensory neuropathy. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations that cause progressive peripheral nerve damage, muscle weakness, and sensory loss. Individuals experiencing symptoms such as delayed motor development, foot deformities, muscle atrophy, or sensory disturbances should consider this test. The test provides crucial information for accurate diagnosis, family planning decisions, and personalized treatment approaches. Available for $500 USD, this advanced genetic analysis offers definitive answers for patients and families affected by this challenging neurological condition.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PRX Gene Dejerine-Sottas Disease NGS Genetic DNA Test

Understanding Dejerine-Sottas Disease and PRX Gene Testing

Dejerine-Sottas disease represents a severe form of hereditary motor and sensory neuropathy (HMSN) characterized by progressive peripheral nerve damage that typically manifests in early childhood. The PRX Gene Dejerine-Sottas Disease NGS Genetic DNA Test employs advanced next-generation sequencing technology to identify mutations in the PRX (periaxin) gene, which plays a crucial role in maintaining the structural integrity of peripheral nerves. This comprehensive genetic analysis provides definitive diagnostic information for patients presenting with symptoms of this debilitating neurological condition.

What Does the PRX Gene Test Measure?

This sophisticated genetic test specifically targets and analyzes the PRX gene to detect pathogenic variants associated with Dejerine-Sottas disease. The test examines:

  • Complete coding regions of the PRX gene
  • Exon-intron boundaries for splicing mutations
  • Copy number variations and large deletions
  • Point mutations and small insertions/deletions
  • All known pathogenic variants linked to peripheral neuropathies

Who Should Consider PRX Gene Testing?

Clinical Indications and Symptoms

This genetic test is recommended for individuals presenting with:

  • Early-onset progressive muscle weakness in extremities
  • Delayed motor milestones in childhood development
  • Significant sensory loss and numbness
  • Foot deformities including pes cavus (high arches)
  • Progressive muscle atrophy and wasting
  • Reduced or absent deep tendon reflexes
  • Family history of hereditary neuropathies
  • Unexplained peripheral nerve dysfunction

Benefits of PRX Gene Dejerine-Sottas Disease Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Definitive Diagnosis: Confirms or rules out Dejerine-Sottas disease with high accuracy
  • Family Planning: Enables informed reproductive decisions for at-risk families
  • Personalized Treatment: Guides targeted therapeutic interventions and management strategies
  • Prognostic Information: Provides insight into disease progression and expected outcomes
  • Genetic Counseling: Supports comprehensive family risk assessment and education
  • Research Contribution: Advances understanding of peripheral neuropathies

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your PRX gene test results:

Positive Result

A positive result indicates the presence of pathogenic mutations in the PRX gene, confirming the diagnosis of Dejerine-Sottas disease. Our genetic counselors will explain the specific mutation identified, its inheritance pattern, and implications for family members.

Negative Result

A negative result suggests that no pathogenic PRX gene mutations were detected. However, this does not completely rule out hereditary neuropathy, as other genetic causes may be involved. Further testing may be recommended based on clinical presentation.

Variant of Uncertain Significance (VUS)

If a genetic change of unknown clinical significance is identified, our team will provide guidance on interpretation and may recommend periodic re-evaluation as scientific knowledge advances.

Test Pricing and Information

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

To ensure optimal testing outcomes, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create a detailed family pedigree
  • Documentation of affected family members with similar symptoms
  • Neurological examination findings

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service nationwide.

Take Control of Your Neurological Health

Don’t let uncertainty about hereditary neuropathies impact your quality of life. The PRX Gene Dejerine-Sottas Disease NGS Genetic DNA Test provides the clarity needed for informed medical decisions and personalized care planning. Our team of neurological genetics specialists is ready to support you through every step of the testing process.

Ready to schedule your genetic test? Call our dedicated genetics team today at +1(267) 388-9828 or book your appointment online. Take the first step toward definitive diagnosis and comprehensive neurological care.